Annals of Oncology with the education program while only 3,1 % were dissatisfied. The rest of the respondents, 9,3% were neither satisfied nor dissatisfied. Conclusions: At the end of the study, our findings were generally comparable to those in the literature and all the indicators were achieved. Therefore, this pilot program should be fully implemented. Legal entity responsible for the study: The authors. Funding: Has not received any funding. Disclosure: All authors have declared no conflicts of interest.
iGestSa ude: Application for self-management of symptoms during chemotherapy treatment
B. Magalhaes1, C. Fernandes2, C. Santos3, J.M. Galiano4 Cirurgia, Instituto Portugues de Oncologia Centro do Porto E.P.E. (IPO-Porto), Porto, ude, Universidade Fernando Pessoa, Porto, Portugal, Portugal, 2Escola Superior de Sa 3 Enfermagem, Escola Superior de Enfermagem do Porto, Porto, Portugal, 4 Departamento de Enfermerıa, Universidad de Jae´n, Jae´n, Spain
1
Background: The main objective of this project is to develop a mobile application (APP) for monitoring and controlling the management of the therapeutic regime in this group of people, with a view to strengthening communication among patients and health professionals, favoring adherence to therapeutic indications and responding, in a timely manner and in a proactive manner, to the symptoms or complications that may arise associated with the disease, thereby improving the efficacy of the therapy,
Volume 30 | Supplement 5 | October 2019
preventing complications and improving its perception of health and quality of life. In fact, health interventions must transform behavior towards the desired improvement and empowerment of the person, thus facilitating self-management. Its final presentation will be on the form of an APP, which will improve the well-being and quality of life of people with cancer, bringing gains in efficiency and health outcomes, broadening the sense of the adequacy of policies of health. The expected results with the implementation of this APP are: improve and monitor patient adherence to oral and supportive therapies; to prevent, the appearance of complications or symptoms associated with the treatment, through preventive indications of self-care (green alert level); improve patients responses, through self-care uncontrolled complications (yellow alert level); signaling to the patient and health services, uncontrolled symptoms with high severity (red alert level); improve the efficiency of health teams with regard to self-management of the disease and produce and disseminate knowledge in oncology. At this time the project is already at an advanced stage of development. Systematic reviews of the literature were developed to support the interventions included in the APP. The interventions were categorized by the two levels of self-care and were submitted to expert evaluation using the Delphi technique. Trial design: Systematic reviews of the literature were developed to support the interventions included in the APP. The interventions were categorized by the two levels of self-care and were submitted to expert evaluation using the Delphi technique. The project has already been tested on an initial sample of 40 patients. Legal entity responsible for the study: The authors. Funding: Has not received any funding. Disclosure: All authors have declared no conflicts of interest.
doi:10.1093/annonc/mdz272 | v821
Downloaded from https://academic.oup.com/annonc/article-abstract/30/Supplement_5/mdz272.018/5578135 by guest on 25 October 2019
CN19
abstracts